Dr. Andrew Hsieh secures $1 million grant to develop therapies for drug-resistant prostate cancer
Dr. Andrew Hsieh from Fred Hutch has received a $1 million grant from the Prostate Cancer Foundation to collaborate with the Institute of Cancer Research in London. Their goal is to develop new therapies for drug-resistant prostate cancer.
Current treatments often fail as cancer adapts, finding ways to grow without androgens. Hsieh's research focuses on mRNA translation, a process that could reveal new vulnerabilities in tumors that have bypassed traditional therapies.
The team plans to study tumor samples to identify which cancers rely on mRNA translation. They will test existing and new drugs, including one already approved by the FDA, to find effective treatments for advanced prostate cancer.